G47.35 Congenital central alveolar hypoventilation syndrome

Name of the Condition

• Congenital Central Alveolar Hypoventilation Syndrome (ICD-10-CM: G47.35)

Summary

Congenital central alveolar hypoventilation syndrome is a rare genetic disorder characterized by impaired respiratory drive, particularly during sleep. Individuals with this condition have difficulty initiating or maintaining adequate breathing, leading to low oxygen levels (hypoxemia) and elevated carbon dioxide (hypercapnia). The condition is present from birth and requires lifelong management to prevent complications.

Causes

The syndrome is caused by mutations in the PHOX2B gene, which plays a critical role in the development of the autonomic nervous system and respiratory control centers. These genetic changes disrupt the brain's ability to regulate breathing, especially during sleep or when unconscious. The condition is typically inherited in an autosomal dominant pattern, though sporadic cases can occur.

Risk Factors

• Family history of the syndrome or related autonomic disorders.
• Genetic mutations in the PHOX2B gene.
• Associated congenital anomalies, such as Hirschsprung disease or neural crest disorders.

Symptoms

• Marked hypoventilation during sleep, often leading to cyanosis or apnea.
• Daytime symptoms may include lethargy, headaches, or shortness of breath.
• In severe cases, respiratory failure or neurodevelopmental delays due to chronic hypoxia.

Diagnosis

Diagnosis is confirmed through clinical evaluation, including sleep studies (polysomnography) to assess breathing patterns and oxygen levels during sleep. Genetic testing for PHOX2B mutations is often performed to confirm the diagnosis. Additional tests may evaluate for associated conditions like Hirschsprung disease.

Treatment Options

• Mechanical ventilation: Non-invasive or invasive support (e.g., tracheostomy) to assist with breathing, especially during sleep.
• Oxygen therapy: Supplemental oxygen to maintain adequate oxygen saturation.
• Monitoring: Regular assessment of respiratory function and associated conditions.
• Multidisciplinary care: Coordination with pulmonologists, geneticists, and neurologists for comprehensive management.

Prognosis and Follow-Up

Prognosis depends on the severity of the condition and the timeliness of treatment. With appropriate ventilation support, many individuals can lead relatively normal lives. Lifelong follow-up is necessary to monitor respiratory function, manage complications, and address associated health issues. Early intervention improves outcomes and reduces the risk of long-term damage.

Complications

• Chronic respiratory failure.
• Pulmonary hypertension.
• Neurodevelopmental delays due to prolonged hypoxia.
• Associated conditions like Hirschsprung disease or cardiac abnormalities.

Lifestyle & Prevention

• Avoid sedatives or medications that suppress breathing.
• Ensure consistent use of prescribed ventilation support during sleep.
• Maintain regular follow-up with healthcare providers to adjust treatment as needed.
• Educate caregivers on recognizing signs of respiratory distress.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe shortness of breath, cyanosis, or signs of respiratory failure. Regular check-ups are essential for monitoring and managing the condition, especially in children or those with new or worsening symptoms.

Tips for Medical Coders

Document the presence of hypoventilation during sleep, genetic testing results (if available), and any associated conditions (e.g., Hirschsprung disease) to support accurate coding. Ensure the code G47.35 is used when the condition is congenital and not secondary to other causes. Include details on ventilation support or oxygen therapy in the medical record for clarity.